Mtorc2 critically regulates renal potassium handling

Journal of Clinical Investigation

Volumn 126, Issue 5, 2016, Pages 1773-1782

  Grahammer, Florian ^a   Nesterov, Viatcheslav ^b   Ahmed, Azaz ^c   Steinhardt, Frederic ^a   Sandner, Lukas ^a   Arnold, Frederic ^a   Cordts, Tomke ^a   Negrea, Silvio ^a   Bertog, Marko ^b   Ruegg, Marcus A ^d   Hall, Michael N ^d   Walz, Gerd ^a   Korbmacher, Christoph ^b   Artunc, Ferruh ^a,c,f   Huber, Tobias B ^a,e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BARIUM ION; EPITHELIAL SODIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; POTASSIUM; POTASSIUM ION; PROTEIN KINASE C ALPHA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM ION; INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ1 PROTEIN, MOUSE; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ALDOSTERONE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH POTASSIUM INTAKE; HYPERKALEMIA; KALIURESIS; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; MOUSE; NONHUMAN; PATCH CLAMP TECHNIQUE; PHENOTYPE; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; POTASSIUM METABOLISM; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SODIUM EXCRETION; SODIUM RESTRICTION; ANIMAL; ELECTROLYTE BALANCE; GENETICS; KIDNEY TUBULE; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; HYPERKALEMIA; KIDNEY TUBULES; MICE; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; POTASSIUM; POTASSIUM CHANNELS, INWARDLY RECTIFYING; TOR SERINE-THREONINE KINASES; WATER-ELECTROLYTE BALANCE;

EID: 84969208677     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI80304     Document Type: Article

References (40)

1. Loewith R, et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell. 2002;10(3):457-468.
2. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124(3):471-484.
3. Grahammer F, Wanner N, Huber TB. mTOR controls kidney epithelia in health and disease. Nephrol Dial Transplant. 2014;29(suppl 1):i9-i18.
4. Huber TB, Walz G, Kuehn EW. mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney Int. 2011;79(5):502-511.
5. Grahammer F, et al. mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proc Natl Acad Sci U S A. 2014;111(27):E2817-E2826.
6. Pearce LR, Sommer EM, Sakamoto K, Wullschleger S, Alessi DR. Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. Biochem J. 2011;436(1):169-179.
7. Peterson TR, et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell. 2009;137(5):873-886.
8. Woo SY, et al. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. J Biol Chem. 2007;282(35):25604-25612.
9. Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 2008;27(14):1919-1931.
10. Lamming DW, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335(6076):1638-1643.
11. Zinzalla V, Stracka D, Oppliger W, Hall MN. Activation of mTORC2 by association with the ribosome. Cell. 2011;144(5):757-768.
12. Bentzinger CF, et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 2008;8(5):411-424.
13. Guertin DA, et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev Cell. 2006;11(6):859-871.
14. Hagiwara A, et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012;15(5):725-738.
15. Kumar A, et al. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and wholebody glucose and lipid metabolism. Diabetes. 2010;59(6):1397-1406.
16. Canaud G, et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med. 2013;19(10):1288-1296.
17. Godel M, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011;121(6):2197-2209.
18. Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J. 2008;416(3):375-385.
19. Lu M, Wang J, Ives HE, Pearce D. mSIN1 protein mediates SGK1 protein interaction with mTORC2 protein complex and is required for selective activation of the epithelial sodium channel. J Biol Chem. 2011;286(35):30647-30654.
20. Lu M, et al. mTOR complex-2 activates ENaC by phosphorylating SGK1. J Am Soc Nephrol. 2010;21(5):811-818.
21. McCormick JA, Bhalla V, Pao AC, Pearce D. SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption. Physiology (Bethesda). 2005;20:134-139.
22. Pao AC. SGK regulation of renal sodium transport. Curr Opin Nephrol Hypertens. 2012;21(5):534-540.
23. Yun CC, et al. The serum and glucocorticoidinducible kinase SGK1 and the Na+ /H+ exchange regulating factor NHERF2 synergize to stimulate the renal outer medullary K+ channel ROMK1. J Am Soc Nephrol. 2002;13(12):2823-2830.
24. Lang F, Shumilina E. Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1. FASEB J. 2013;27(1):3-12.
25. Mansley MK, Wilson SM. Dysregulation of epithelial Na+ absorption induced by inhibition of the kinases TORC1 and TORC2. Br J Pharmacol. 2010;161(8):1778-1792.
26. Gleason CE, et al. mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity. J Clin Invest. 2014;125(1):117-128.
27. Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol. 2002;13(7):1837-1846.
28. Fejes-Toth G, Frindt G, Naray-Fejes-Toth A, Palmer LG. Epithelial Na+ channel activation and processing in mice lacking SGK1. Am J Physiol Renal Physiol. 2008;294(6):F1298-F1305.
29. Wulff P, et al. Impaired renal Na+ retention in the sgk1-knockout mouse. J Clin Invest. 2002;110(9):1263-1268.
30. Weinstein AM. Potassium excretion during antinatriuresis: perspective from a distal nephron model. Am J Physiol Renal Physiol. 2012;302(6):F658-F673.
31. Wang WH, Giebisch G. Regulation of potassium (K) handling in the renal collecting duct. Pflugers Arch. 2009;458(1):157-168.
32. Rubera I, et al. Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance. J Clin Invest. 2003;112(4):554-565.
33. Berger S, et al. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc Natl Acad Sci U S A. 1998;95(16):9424-9429.
34. McDonald FJ, et al. Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A. 1999;96(4):1727-1731.
35. Loffing J, Korbmacher C. Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC). Pflugers Arch. 2009;458(1):111-135.
36. Lin D, Sterling H, Lerea KM, Giebisch G, Wang WH. Protein kinase C (PKC)-induced phosphorylation of ROMK1 is essential for the surface expression of ROMK1 channels. J Biol Chem. 2002;277(46):44278-44284.
37. Holtzclaw JD, Grimm PR, Sansom SC. Role of BK channels in hypertension and potassium secretion. Curr Opin Nephrol Hypertens. 2011;20(5):512-517.
38. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274-293.
39. Chen Z, et al. Activation of mTORC1 in collecting ducts causes hyperkalemia. J Am Soc Nephrol. 2014;25(3):534-545.
40. Penton D, Czogalla J, Loffing J. Dietary potassium and the renal control of salt balance and blood pressure. Pflugers Arch. 2015;467(3):513-530.